OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 33 filers reported holding OPIANT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21,700 | +334.0% | 1,070 | +178.6% | 0.00% | – |
| Q2 2022 | $5,000 | 0.0% | 384 | +52.4% | 0.00% | – |
| Q1 2022 | $5,000 | -37.5% | 252 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | +33.3% | 252 | -4.9% | 0.00% | – |
| Q3 2021 | $6,000 | +100.0% | 265 | +5.2% | 0.00% | – |
| Q2 2021 | $3,000 | -80.0% | 252 | -82.5% | 0.00% | – |
| Q1 2021 | $15,000 | +275.0% | 1,437 | +282.2% | 0.00% | – |
| Q1 2020 | $4,000 | -42.9% | 376 | -20.8% | 0.00% | – |
| Q4 2019 | $7,000 | -30.0% | 475 | -28.1% | 0.00% | – |
| Q3 2019 | $10,000 | +66.7% | 661 | +39.2% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 475 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +500.0% | 475 | +375.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -97.3% | 100 | -90.0% | 0.00% | – |
| Q3 2017 | $37,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 210,000 | $2,518,000 | 5.80% |
| APIS CAPITAL ADVISORS, LLC | 196,000 | $2,350,000 | 2.65% |
| Stonepine Capital Management, LLC | 152,278 | $1,826,000 | 0.85% |
| Parkman Healthcare Partners LLC | 75,632 | $907,000 | 0.33% |
| PERRITT CAPITAL MANAGEMENT INC | 30,500 | $366,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 50,405 | $604,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 126,978 | $1,523,000 | 0.01% |
| Trexquant Investment LP | 12,219 | $147,000 | 0.01% |
| Renaissance Technologies | 193,415 | $2,319,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 74,400 | $892,000 | 0.00% |